Damora Therapeutics, Inc. (DMRA): SCHEDULE 13G/A filed Mar 6, 2026

Form type

SCHEDULE 13G/A

Filing date

Mar 6, 2026

Accession number

0001193125-26-096746

Filer

Damora Therapeutics, Inc. (CIK 1800315)